Arnall Patz Distinguished Professor of OPhthalmology
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
Dr. Kannan Rangaramanujam is the Arnall Patz distinguished professor of ophthalmology and co-director of center for nanomedicine at the Wilmer Eye Institute at Johns Hopkins School of Medicine. He obtained his Ph.D. in Chemical Engineering from Caltech and followed with a postdoctoral stint at the University of Minnesota. His research interests are in the field of translational nanomedicine centered on a unique hydroxyl dendrimer platform technology. His team has developed approaches to target and manipulate injured glia/macrophages specifically, from systemic administration. Targeted therapies for neuroinflammation and angiogenesis are being developed with this approach, with significant implications for addressing unmet needs in CNS, systemic and ocular disorders, and cancer. Dr. Kannan is an inventor on >100 patents (issued and pending, licensed), more than 130 peer-reviewed publications. He co-founded Ashvattha Therapeutics Inc., the spinoff that is translating his team’s research in neurology and ophthalmology to the clinic, with promising early clinical results.
Disclosure information not submitted.
Tech Session II: Nanomedicine and Nanoscale Delivery (Focus: Nervous)
Tuesday, July 15, 2025
2:00 PM - 4:00 PM EDT
